In Depth 17 Jun 2024
Moving with the times: biopharma royalty deals on the rise
A spate of royalty deals are changing the way certain biotechs press ahead. This trend seems to be an alternative to traditional biopharma fundraising.
Funding
- Latest Posts
Best in Biotech 13 Jun 2024
Eight companies tackling cancer with allogeneic cell therapy in 2024
Unlike autologous cell therapy, where the patient’s own cells are used, allogeneic cell therapy companies leverage donor cells, which can come from various sources such as bone marrow or umbilical cord blood. In allogeneic cell therapy, healthy donor cells are harvested, processed, and then infused into the patient. These donor cells can differentiate into various […]
Best in Biotech 11 Jun 2024
Finland: Pushing biotech forward in the land of a thousand lakes
Explore seven leading biotech companies driving Finland’s biotech sector forward in precision medicine, immunotherapy, and more.
In Depth 3 Jun 2024
The biggest private biotech investments in May 2024
The companies Uniquity Bio, AltruBio, and BridgeBio Oncology Therapeutics bagged the biggest private biotech investments in May 2024.
In Depth 30 May 2024
Covalent biologics: a new class of drugs on the horizon
The field of covalent biologics has made headway recently, as the only biotech in the space has bagged $100 million to move its pipeline to the clinic.
Best in Biotech 21 May 2024
Eight companies spearheading Philadelphia’s biotech industry
Often called the Cellicon Valley due to its focus on cell and gene therapy, discover eight Philadelphia biotech companies to know about.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 14 May 2024
Six biotechs in Belgium making leaps in the clinic
Meet the most successful biotech companies in Belgium, a country that makes a huge contribution to the biotech industry.
In Depth 9 May 2024
The biggest private biotech investments in April 2024
The companies Xaira Therapeutics, Metsera, and Obsidian Therapeutics bagged the biggest private biotech investments in April 2024.
Best in Biotech 7 May 2024
Biotech in New Jersey: Nine companies leading the charge
Delve into one of the most dynamic biotech region in the U.S. and discover nine New-Jersey-based companies to put on your radar.
Best in Biotech 2 May 2024
Eight monoclonal antibody biotechs making strides in the clinic
In this article, we take a look at eight biotechs advancing their monoclonal antibodies through the clinic that have made the news in recent times.
In Depth 22 Apr 2024
The biggest private biotech investments in March 2024
The companies Mirador Therapeutics, Alumis, and Sionna Therapeutics bagged the biggest private biotech investments in March 2024.
Podcast 19 Apr 2024
The biotech investment landscape in 2024
Dive into 2024’s biotech investment strategies with RTW Investments on our podcast. Discover trends shaping the landscape ahead.”
ADVERTISEMENT
